P2RX7 Enhances Tumor Control by CD8+ T Cells in Adoptive Cell Therapy.
Ontology highlight
ABSTRACT: Expression of the purinergic receptor P2RX7 by CD8+ T cells promotes the generation of memory populations following acute infections. However, data suggest that P2RX7 may limit the efficacy of antitumor responses. Herein, we show that P2RX7 is beneficial for optimal melanoma control in a mouse CD8+ T-cell adoptive transfer model. Tumor-specific P2rx7-/- CD8+ T cells exhibited impaired mitochondrial maintenance and function but did not display signs of overt exhaustion early in the antitumor response. However, as the tumor burden increased, the relative frequency of P2RX7-deficient CD8+ T cells declined within the tumor; this correlated with reduced proliferation, increased apoptosis, and mitochondrial dysfunction. Extending these studies, we found that the transient in vitro stimulation of
SUBMITTER: Wanhainen KM
PROVIDER: S-EPMC9250641 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA